Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP165046.RAWrcZQOzoxQcYqhxbzQTjfnFKvXJNXbdyRbykNPP4sLQ130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165046.RAWrcZQOzoxQcYqhxbzQTjfnFKvXJNXbdyRbykNPP4sLQ130_provenance.
• NP165048.RARXlccwM6CHxv4SU4NHDHXrGChEJQ38Rm99EsStiqsNw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165048.RARXlccwM6CHxv4SU4NHDHXrGChEJQ38Rm99EsStiqsNw130_provenance.
• NP165050.RAca5RV3DB_OV-CUFp37NOjUybHX3_MyF33w1ogFLQkMo130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165050.RAca5RV3DB_OV-CUFp37NOjUybHX3_MyF33w1ogFLQkMo130_provenance.
• NP165051.RAQ50YDeI-xDqTNo8akS5vEVUiqXq8phno0dC1G_lgQY0130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165051.RAQ50YDeI-xDqTNo8akS5vEVUiqXq8phno0dC1G_lgQY0130_provenance.
• NP165052.RAdjb8oKbQAGNlbFL_Y-oHCIFOqIrqO9IKhTlbAPNg7S0130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165052.RAdjb8oKbQAGNlbFL_Y-oHCIFOqIrqO9IKhTlbAPNg7S0130_provenance.
• NP165055.RAfG25sntgcxRV2g64zj-xk8sCYnQwFFbRw2cUA-phP-c130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165055.RAfG25sntgcxRV2g64zj-xk8sCYnQwFFbRw2cUA-phP-c130_provenance.
• NP165062.RAdnmWhmu94YpYGwVnl-93H00AroQeZ5Q_6UPUYSlSHZE130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165062.RAdnmWhmu94YpYGwVnl-93H00AroQeZ5Q_6UPUYSlSHZE130_provenance.
• NP165066.RAZvH2gDs6v8oWmn0uxJPWj5qy-6EJ02_HitdMTOAWuzc130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165066.RAZvH2gDs6v8oWmn0uxJPWj5qy-6EJ02_HitdMTOAWuzc130_provenance.
• NP165071.RAci51DyDC2J0dg1MRnT3tfywkQouEm4QGIXfmY7v98Is130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165071.RAci51DyDC2J0dg1MRnT3tfywkQouEm4QGIXfmY7v98Is130_provenance.
• NP165074.RAZdi56_4gqquyO1BmmkBqX9R5XUF_BaTXI0_L7pglN1w130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165074.RAZdi56_4gqquyO1BmmkBqX9R5XUF_BaTXI0_L7pglN1w130_provenance.
• NP165077.RARhYHrXUP2L3iX193-dA7Dd5Ag_dENTS_8WA1ovCP2x4130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165077.RARhYHrXUP2L3iX193-dA7Dd5Ag_dENTS_8WA1ovCP2x4130_provenance.
• NP165083.RAUaT0jmFlkNzHZyTiz61PGnwG34HufLVcCJwZQ5Ub9TI130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165083.RAUaT0jmFlkNzHZyTiz61PGnwG34HufLVcCJwZQ5Ub9TI130_provenance.
• NP165086.RAX_NJDFFFeInwRhypCRz1qdVBiq-R2bEbqe6Di9fcnYM130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165086.RAX_NJDFFFeInwRhypCRz1qdVBiq-R2bEbqe6Di9fcnYM130_provenance.
• NP165091.RAd4MiMP-r5iMpv6m7N7QdeCV-IIJm5ylUxtOMjSA1VjQ130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165091.RAd4MiMP-r5iMpv6m7N7QdeCV-IIJm5ylUxtOMjSA1VjQ130_provenance.
• NP165094.RAXfVD4faLpDH7jLPTrjmzsf58Mw23nJVseNmZQ2INu1Q130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165094.RAXfVD4faLpDH7jLPTrjmzsf58Mw23nJVseNmZQ2INu1Q130_provenance.
• NP70106.RAry0ZI-R46TH7UQjUWslpsfQy5M1sIaa4FTKekSdH5Tc130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP70106.RAry0ZI-R46TH7UQjUWslpsfQy5M1sIaa4FTKekSdH5Tc130_provenance.
• NP70136.RAqdPDKAJIbROKdM2DBCDJVMzAt54ltSdwVf3ydc68J_o130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP70136.RAqdPDKAJIbROKdM2DBCDJVMzAt54ltSdwVf3ydc68J_o130_provenance.
• NP74578.RAgHa39YuOAymxYW4D3RaikAmYLTIdWVJUlw9SH9-B9GY130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74578.RAgHa39YuOAymxYW4D3RaikAmYLTIdWVJUlw9SH9-B9GY130_provenance.
• NP77703.RAmRSj060hJcJPy9VFLfZWdTYi3y7B87-6R9gHTflbZYM130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77703.RAmRSj060hJcJPy9VFLfZWdTYi3y7B87-6R9gHTflbZYM130_provenance.
• NP78168.RAk352iPLm97UX3nzDnzJ1evoCBm9y0Am-A9dyye_iaNw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78168.RAk352iPLm97UX3nzDnzJ1evoCBm9y0Am-A9dyye_iaNw130_provenance.
• NP78851.RAsbo-Q_jmiJzPzi2w9JPZoMPrDr_jJSaMTxDorc1eHBk130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78851.RAsbo-Q_jmiJzPzi2w9JPZoMPrDr_jJSaMTxDorc1eHBk130_provenance.
• NP78898.RAgN2G1qwYkOfELi7dKdjvGAmMmh1LAi_sQ6muEFCG7Gw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78898.RAgN2G1qwYkOfELi7dKdjvGAmMmh1LAi_sQ6muEFCG7Gw130_provenance.
• NP84803.RArTcLwd-Q9WC8fCrFPLgur6SmWeJldLGSWKBfdSLd7Aw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84803.RArTcLwd-Q9WC8fCrFPLgur6SmWeJldLGSWKBfdSLd7Aw130_provenance.
• NP96669.RAnCCEdK8ZfG8ocHdfApBm0qKjKtd_uQr4YZWGX3kuNVk130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96669.RAnCCEdK8ZfG8ocHdfApBm0qKjKtd_uQr4YZWGX3kuNVk130_provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP133033.RAAAu1XkXNm2k9wIPpYbESq2WWKvki3wrDb6MjSP7hfGY130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133033.RAAAu1XkXNm2k9wIPpYbESq2WWKvki3wrDb6MjSP7hfGY130_provenance.
• NP133140.RACmb2_kp0Ncc_HeDpIvKCsbRfEiZSSD81Fr10lPb0K4k130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133140.RACmb2_kp0Ncc_HeDpIvKCsbRfEiZSSD81Fr10lPb0K4k130_provenance.
• NP795052.RABvhS9AWSRUptpDdBiFtoS2ewzPb2AzPQLHcpxGmXiWw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795052.RABvhS9AWSRUptpDdBiFtoS2ewzPb2AzPQLHcpxGmXiWw130_provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP795055.RASQVQ027IQ3k5tiwTy2Ye324fhtlS1zh1Dxzs-QBkVo8130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795055.RASQVQ027IQ3k5tiwTy2Ye324fhtlS1zh1Dxzs-QBkVo8130_provenance.
• NP50000.RAzdwQa1OkvkB-Gh7PIWjtRU8vd9eGa04ERerkPVJ72dw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50000.RAzdwQa1OkvkB-Gh7PIWjtRU8vd9eGa04ERerkPVJ72dw130_provenance.
• NP165076.RACtVnZnpfglnanASHbz2ZFYhItyiHcLXgBfV5dOYl2w4130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165076.RACtVnZnpfglnanASHbz2ZFYhItyiHcLXgBfV5dOYl2w4130_provenance.
• NP165082.RAAy-O64icY6EWxcHyR_BmyM0Ufehgw2Oa3Sn7AuzK1iU130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165082.RAAy-O64icY6EWxcHyR_BmyM0Ufehgw2Oa3Sn7AuzK1iU130_provenance.
• NP165095.RABnHKchx4LkwDNQt2vPINsyIbcRq6w-o_c3Xd72smd3g130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165095.RABnHKchx4LkwDNQt2vPINsyIbcRq6w-o_c3Xd72smd3g130_provenance.
• NP683739.RAhHaP_376Oont5nYhFE2pxtuMHF7NiE7_CR-V5l3WFSY130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683739.RAhHaP_376Oont5nYhFE2pxtuMHF7NiE7_CR-V5l3WFSY130_provenance.
• NP165035.RAoN42Gi74RW1KyDilHmxbGkWimwBy8ud53xQNJ9jTa5A130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165035.RAoN42Gi74RW1KyDilHmxbGkWimwBy8ud53xQNJ9jTa5A130_provenance.
• NP165039.RApe01DsdhB4uFVLmOrKQjOHzXybU0Wrcey5i4cRFfUW4130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165039.RApe01DsdhB4uFVLmOrKQjOHzXybU0Wrcey5i4cRFfUW4130_provenance.
• NP165041.RAk7PjCW_Ztr-34-bLCcWGLmMyVe7rcX5mMLYw2szTw9E130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165041.RAk7PjCW_Ztr-34-bLCcWGLmMyVe7rcX5mMLYw2szTw9E130_provenance.
• NP165049.RAvCzZKEkkOG_yoTD1fV6lO8oQUJoPOYZggEjf3tOQXiA130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165049.RAvCzZKEkkOG_yoTD1fV6lO8oQUJoPOYZggEjf3tOQXiA130_provenance.
• NP165059.RAsw--73czerglZoC051ycS1LKGdfw63z_rU-Jt7Q6bHI130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165059.RAsw--73czerglZoC051ycS1LKGdfw63z_rU-Jt7Q6bHI130_provenance.
• NP165060.RAgDxBO4yZdfkuhicbnr3cIWe84oJCu4udBBujGVdrMEs130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165060.RAgDxBO4yZdfkuhicbnr3cIWe84oJCu4udBBujGVdrMEs130_provenance.
• NP165064.RArFY6tthPCGs3XI1K5jkEuqmQFoumqwUwUzm4EZ7OiH4130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165064.RArFY6tthPCGs3XI1K5jkEuqmQFoumqwUwUzm4EZ7OiH4130_provenance.
• NP165067.RAvrf1okxyHYlSYoZwR4d0ifVzG0YmnQnMSMUai08Mj7E130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165067.RAvrf1okxyHYlSYoZwR4d0ifVzG0YmnQnMSMUai08Mj7E130_provenance.
• NP165068.RAoZ-hb-mVMFcfNmU0yfifLTpZA9l7RWCmKIorFz2GJew130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165068.RAoZ-hb-mVMFcfNmU0yfifLTpZA9l7RWCmKIorFz2GJew130_provenance.
• NP165069.RAg7uogFYmJwmO56aGYk9vWHE9sFFZgl3MgGbto67mkhE130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165069.RAg7uogFYmJwmO56aGYk9vWHE9sFFZgl3MgGbto67mkhE130_provenance.
• NP165070.RAnqZq2DMWV4KKmMNWIA373sp6yNQmO-QiDLExGvRyNZo130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165070.RAnqZq2DMWV4KKmMNWIA373sp6yNQmO-QiDLExGvRyNZo130_provenance.
• NP165072.RAnzYulocT5bJm5g0B_44DcWzER9Rdgg1ZFOEhK6z5hLc130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165072.RAnzYulocT5bJm5g0B_44DcWzER9Rdgg1ZFOEhK6z5hLc130_provenance.
• NP165079.RAtyHnKwrAY0yfxUJ4k6CIB1jRsf7LcrJZFY_ufWci0c8130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165079.RAtyHnKwrAY0yfxUJ4k6CIB1jRsf7LcrJZFY_ufWci0c8130_provenance.
• NP165080.RAqx0d-KAnb4hBOlD7ON6bWW4CeAUdK-12T7C4y5ZMO6s130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165080.RAqx0d-KAnb4hBOlD7ON6bWW4CeAUdK-12T7C4y5ZMO6s130_provenance.
• NP165084.RAk8gAjGTZcaDSs42WN7DTjpCfnXHUO5RgrWJT8iJ7-eI130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165084.RAk8gAjGTZcaDSs42WN7DTjpCfnXHUO5RgrWJT8iJ7-eI130_provenance.
• NP165087.RAmOjcxNAAk7jXYLMad7iHpeC7OFld2de85TyyCFCYOaQ130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165087.RAmOjcxNAAk7jXYLMad7iHpeC7OFld2de85TyyCFCYOaQ130_provenance.
• NP165088.RApqYJp2WI3CZECg-ai1owtsiEkg3yOh652Cgm0B9tEAU130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165088.RApqYJp2WI3CZECg-ai1owtsiEkg3yOh652Cgm0B9tEAU130_provenance.
• NP165090.RAojC4JL4-3SvjJSq16wci4qurUOLP8kB3YLFonz7hNj0130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165090.RAojC4JL4-3SvjJSq16wci4qurUOLP8kB3YLFonz7hNj0130_provenance.
• NP165092.RAvw_lvuz6nS7cO4us0zVGex-rUjj2P_M_5p1vL2_bJBw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165092.RAvw_lvuz6nS7cO4us0zVGex-rUjj2P_M_5p1vL2_bJBw130_provenance.
• NP165093.RAmlDTwJdw6SOktCJdHmoqqyM_t4Ap6owySnD5JSk1Tms130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165093.RAmlDTwJdw6SOktCJdHmoqqyM_t4Ap6owySnD5JSk1Tms130_provenance.
• NP795053.RArxf_pHHrIleuCplP20FpTHkDgEYsIHesAWAgE3NjITI130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795053.RArxf_pHHrIleuCplP20FpTHkDgEYsIHesAWAgE3NjITI130_provenance.
• NP795054.RApNb4SOnAzF0cFmU7wm1Z7wPrUVE5fIrX6gsBPSTxEb8130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795054.RApNb4SOnAzF0cFmU7wm1Z7wPrUVE5fIrX6gsBPSTxEb8130_provenance.
• NP74590.RA1K4Fchd5De8XcXsCS2ivunoIyVSwzS31Sv0Yo53MWOA130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74590.RA1K4Fchd5De8XcXsCS2ivunoIyVSwzS31Sv0Yo53MWOA130_provenance.
• NP77752.RA0e7KK1eb8t4_Joh4gmRj7hpIGJGjN9Kw9AHq7e20j5Y130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77752.RA0e7KK1eb8t4_Joh4gmRj7hpIGJGjN9Kw9AHq7e20j5Y130_provenance.
• NP78198.RA-PJaNJ3BuknA3I3NIdn_Se0QM4xiuhn7YOowQcWDNYg130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78198.RA-PJaNJ3BuknA3I3NIdn_Se0QM4xiuhn7YOowQcWDNYg130_provenance.
• NP78826.RAzGgHf24GfyjurN20hCyOH99LCT_-U2_5j2TTbjANqtk130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78826.RAzGgHf24GfyjurN20hCyOH99LCT_-U2_5j2TTbjANqtk130_provenance.
• NP96607.RA6VcYnQYJ0MocXj0OHOgzz_-2j2iHTHLwHLRyfdeM438130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96607.RA6VcYnQYJ0MocXj0OHOgzz_-2j2iHTHLwHLRyfdeM438130_provenance.
• NP96702.RA426RQWPomFzZLb27rCCYWr79UqdtM8X8d8UxWBXygtA130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96702.RA426RQWPomFzZLb27rCCYWr79UqdtM8X8d8UxWBXygtA130_provenance.
• NP78881.RAL5TUZuHZGnJtvKX1je930Mzt0xFhAJ-EXdHM5SIqnzQ130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78881.RAL5TUZuHZGnJtvKX1je930Mzt0xFhAJ-EXdHM5SIqnzQ130_provenance.
• NP84784.RANe_x72_lrEocnOifk_RTNKCyTP5WEOxRpESFQII8U40130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84784.RANe_x72_lrEocnOifk_RTNKCyTP5WEOxRpESFQII8U40130_provenance.
• NP84797.RAJfO5Lqord_MnSDhdox0Ln7o4lugIClajB5xZonrSVu0130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84797.RAJfO5Lqord_MnSDhdox0Ln7o4lugIClajB5xZonrSVu0130_provenance.
• NP133022.RA6DDpbrG3lIKdRuIIXHNDQZ7Kv9UCQfhUeGI0mbkBdV8130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133022.RA6DDpbrG3lIKdRuIIXHNDQZ7Kv9UCQfhUeGI0mbkBdV8130_provenance.
• NP133113.RA5uFLLF48FXFPeunclNaQCB8qW_L9Bq5bCGRxxz9LoUU130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133113.RA5uFLLF48FXFPeunclNaQCB8qW_L9Bq5bCGRxxz9LoUU130_provenance.
• NP137196.RA6P9gxcFVkjtflwNq6ycR6B7cL4VQivMutly1OiY3ezM130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137196.RA6P9gxcFVkjtflwNq6ycR6B7cL4VQivMutly1OiY3ezM130_provenance.
• NP146432.RA4vkCo0M8zYaC60QWpVd8Va6lGzfN23XqdFSFGRGEl4Q130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146432.RA4vkCo0M8zYaC60QWpVd8Va6lGzfN23XqdFSFGRGEl4Q130_provenance.
• NP422767.RAxnV46sy2UArNsmBJlkLDXK6ZXtPAHU16lPh_Xmq-OaY130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422767.RAxnV46sy2UArNsmBJlkLDXK6ZXtPAHU16lPh_Xmq-OaY130_provenance.
• NP407134.RA4XGn_sFzsyC4IkMij3m3mn0llpwm-zPEkrrtmUs1JPM130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407134.RA4XGn_sFzsyC4IkMij3m3mn0llpwm-zPEkrrtmUs1JPM130_provenance.
• NP96779.RAElz9e3IRKZC2R-PbPmBseVLDLEzjdDAh8H2M7R42dnU130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP96779.RAElz9e3IRKZC2R-PbPmBseVLDLEzjdDAh8H2M7R42dnU130_provenance.
• NP103718.RAHpAn2XYtIESp7e-4Exgj3kvznO7ySc48S32zohynYF4130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103718.RAHpAn2XYtIESp7e-4Exgj3kvznO7ySc48S32zohynYF4130_provenance.
• NP103946.RAJAm04FdhzXoHaQ_pGqsKStTFGV4oXFe6-zvM42v4HJs130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103946.RAJAm04FdhzXoHaQ_pGqsKStTFGV4oXFe6-zvM42v4HJs130_provenance.
• NP132971.RAEzyp9ou3MT3tDIJOmp7F37Dzs5Xq_kf6_ZK4k5WWgq0130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132971.RAEzyp9ou3MT3tDIJOmp7F37Dzs5Xq_kf6_ZK4k5WWgq0130_provenance.
• NP133034.RAP3KMb4iPGu8QTtHis6boljnDQqPi-WgjLhmTnEsAlTk130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133034.RAP3KMb4iPGu8QTtHis6boljnDQqPi-WgjLhmTnEsAlTk130_provenance.
• NP133072.RAMCcyL-KATB-grf72kdmY9rA70mkn18Q22koYC3HQaAA130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133072.RAMCcyL-KATB-grf72kdmY9rA70mkn18Q22koYC3HQaAA130_provenance.
• NP133073.RAEOf_KO-kT6aw5lbhk0nCLSyaGhFSVO2cyfqwNUX0YXw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133073.RAEOf_KO-kT6aw5lbhk0nCLSyaGhFSVO2cyfqwNUX0YXw130_provenance.
• NP133112.RAGhWsRNdjHPVgtuTAlgijbZhnWoolGykZ1ecbMR5A3OY130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133112.RAGhWsRNdjHPVgtuTAlgijbZhnWoolGykZ1ecbMR5A3OY130_provenance.
• NP524527.RAGhjDI6TeAChiMTRZ4XNd0a-ZvPo7TaJXaSuoUUIDL6U130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524527.RAGhjDI6TeAChiMTRZ4XNd0a-ZvPo7TaJXaSuoUUIDL6U130_provenance.
• NP165031.RAFW0eAA-4-Q-NUgo2s8KTXinINLwvEdZTeaJwrVtZrDA130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165031.RAFW0eAA-4-Q-NUgo2s8KTXinINLwvEdZTeaJwrVtZrDA130_provenance.
• NP165032.RAPMV0Tq7QxoLDI4O9x-mWr9zpTEkkbQdw1heI9MaB17k130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165032.RAPMV0Tq7QxoLDI4O9x-mWr9zpTEkkbQdw1heI9MaB17k130_provenance.
• NP165036.RAJY4vM6Vlbd2XYsRwNEAm9hnGALzue9ELVM-v6s58f58130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165036.RAJY4vM6Vlbd2XYsRwNEAm9hnGALzue9ELVM-v6s58f58130_provenance.
• NP165037.RAOSCmMZrV3pqazy3AwoCrcUquguu0RkSyMFOSSqki-zs130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165037.RAOSCmMZrV3pqazy3AwoCrcUquguu0RkSyMFOSSqki-zs130_provenance.
• NP165054.RAFKYLz3jmLF-PbmqTdGaKOj-or9e9tZsxqJU_LXuYNpg130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165054.RAFKYLz3jmLF-PbmqTdGaKOj-or9e9tZsxqJU_LXuYNpg130_provenance.
• NP165057.RANTogBNoeSHy9FQmZT2EOLxMj5ZFAoJ5XvNYB0e0ZfI0130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165057.RANTogBNoeSHy9FQmZT2EOLxMj5ZFAoJ5XvNYB0e0ZfI0130_provenance.
• NP165058.RAF8Lc5HWoVXCnEmassvg2rt_6oGqvKdSqd7z0e_TKqbw130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165058.RAF8Lc5HWoVXCnEmassvg2rt_6oGqvKdSqd7z0e_TKqbw130_provenance.
• NP165075.RAIWgtrCQmN5DLhXLxq6wuC3v9JyMgobiNPzLP9Rm_zBc130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165075.RAIWgtrCQmN5DLhXLxq6wuC3v9JyMgobiNPzLP9Rm_zBc130_provenance.
• NP165078.RAOtxpSB3Gx0ZUh82PDPgCcvtBwgkEfa4A9IrEOxaEIUA130_assertion description "[The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165078.RAOtxpSB3Gx0ZUh82PDPgCcvtBwgkEfa4A9IrEOxaEIUA130_provenance.

• first
• previous
• next